183 related articles for article (PubMed ID: 22271478)
21. [Aromatase inhibitors in adjuvant setting in breast cancer].
Spano JP; Khayat D; Delozier T
Bull Cancer; 2004 Dec; 91 Suppl 4():S239-43. PubMed ID: 15899615
[TBL] [Abstract][Full Text] [Related]
22. [Optimal adjuvant hormone therapy in postmenopausal women with hormone-sensitive mammary carcinoma: tamoxifen and the aromatase inhibitors anastrozole, exemestane and letrozole].
van Nes JG; Seynaeve C; van de Velde CJ; Nortier JW
Ned Tijdschr Geneeskd; 2006 Dec; 150(52):2863-9. PubMed ID: 17319217
[TBL] [Abstract][Full Text] [Related]
23. Extended therapy with letrozole and ovarian suppression in premenopausal patients with breast cancer after tamoxifen.
Ruddy KJ; DeSantis SD; Barry W; Guo H; Block CC; Borges V; Winer EP; Partridge AH
Clin Breast Cancer; 2014 Dec; 14(6):413-6. PubMed ID: 24970714
[TBL] [Abstract][Full Text] [Related]
24. [The ATAC study on adjuvants in breast cancer].
Bravi S
Suppl Tumori; 2004; 3(4):S15. PubMed ID: 15206200
[No Abstract] [Full Text] [Related]
25. Clinical perspectives on the utility of aromatase inhibitors for the adjuvant treatment of breast cancer.
Chlebowski R; Cuzick J; Amakye D; Bauerfeind I; Buzdar A; Chia S; Cutuli B; Linforth R; Maass N; Noguchi S; Robidoux A; Verma S; Hadji P
Breast; 2009 Aug; 18 Suppl 2():S1-11. PubMed ID: 19712865
[No Abstract] [Full Text] [Related]
26. ATAC trial update.
de Castro G
Lancet; 2005 Apr 2-8; 365(9466):1225; author reply 1225-6. PubMed ID: 15811448
[No Abstract] [Full Text] [Related]
27. Beating breast cancer.
Fricker J
Nurs Stand; 2004 Aug 11-17; 18(48):15. PubMed ID: 15366393
[No Abstract] [Full Text] [Related]
28. Breast cancer (metastatic).
Stebbing J; Crane J; Gaya A
Clin Evid; 2006 Jun; (15):2331-59. PubMed ID: 16973089
[No Abstract] [Full Text] [Related]
29. [New results of endocrine therapy of breast cancer (the role of Aromasin)].
Semiglazov VF; Semiglazov VV; Klemtsel' AA; Barash NIu; Zhil'tsova EK; Bozhok AA; Mel'nikova OA; Paltuev RM; Dashian GA; Petrovskiĭ SG; Ivanov VG; Tonuzov EE; Berstein LM
Vopr Onkol; 2004; 50(6):729-36. PubMed ID: 15755074
[No Abstract] [Full Text] [Related]
30. Letrozole in postmenopausal hormone-responsive early-stage breast cancer: a viewpoint by Gerald M. Higa.
Higa GM
Drugs; 2006; 66(3):363-4. PubMed ID: 16526828
[No Abstract] [Full Text] [Related]
31. Letrozole in breast cancer.
Shahab N
N Engl J Med; 2004 Feb; 350(7):727-30; author reply 727-30. PubMed ID: 14971058
[No Abstract] [Full Text] [Related]
32. Aromatase inhibitors--a triumph of translational oncology.
Swain SM
N Engl J Med; 2005 Dec; 353(26):2807-9. PubMed ID: 16382068
[No Abstract] [Full Text] [Related]
33. [New strategies against breast carcinoma. To outwit the resistance tendency of tumor cells].
Jakesz R
MMW Fortschr Med; 2005 Mar; 147(10):8. PubMed ID: 15803774
[No Abstract] [Full Text] [Related]
34. New breast cancer drugs expand treatment options.
Harv Womens Health Watch; 2002 Apr; 9(8):7. PubMed ID: 11959538
[No Abstract] [Full Text] [Related]
35. [Tamoxifen and aromatase inhibitors in the treatment of breast cancer in menopausal women: pharmacological and clinical aspects].
de Cremoux P; Diéras V; Poupon MF; Magdelénat H; Sigal-Zafrani B; Fourquet A; Pierga JY
Bull Cancer; 2004 Dec; 91(12):917-27. PubMed ID: 15634633
[TBL] [Abstract][Full Text] [Related]
36. Targeting breast cancer with hormonal treatment options.
Mellington TE; Fields MM
Nurse Pract; 2008 May; 33(5):17-22; quiz 22-3. PubMed ID: 18458623
[No Abstract] [Full Text] [Related]
37. Postmenopausal women with DCIS post-mastectomy: a potential role for aromatase inhibitors.
Chlebowski RT; Col N
Breast J; 2012; 18(4):299-302. PubMed ID: 22681627
[TBL] [Abstract][Full Text] [Related]
38. Breast cancer (metastatic).
Stebbing J; Glassman R
Clin Evid; 2005 Jun; (13):2197-225. PubMed ID: 16135325
[No Abstract] [Full Text] [Related]
39. Extended adjuvant therapy for breast cancer--how much is enough?
Prowell TM; Stearns V
J Natl Cancer Inst; 2007 Dec; 99(24):1825-7. PubMed ID: 18073372
[No Abstract] [Full Text] [Related]
40. Anastrozole as an adjuvant endocrine treatment for postmenopausal patients with breast cancer: emerging data.
Buzdar AU; Cuzick J
Clin Cancer Res; 2006 Feb; 12(3 Pt 2):1037s-1048s. PubMed ID: 16467122
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
